
Physician-reviewed TRT comparison
Both are long-acting injectable testosterone esters used for replacement therapy. Their differences are smaller than many online comparisons suggest, and neither is universally better.
Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

Testosterone cypionate and testosterone enanthate are very similar long-acting injectable testosterone esters. Both can effectively restore testosterone in appropriately diagnosed men, and the choice usually comes down to availability, product formulation, carrier oil, cost, tolerability and clinician/patient preference rather than a major difference in effectiveness.
Cypionate generally has a slightly longer ester chain and somewhat longer pharmacokinetic profile, but the practical difference is modest. Dosing and monitoring matter more than choosing one ester based on internet claims.
For a section-by-section reading of what the two FDA labels actually say — including the carrier oils, the approved indications and the one half-life figure that is not on the label most people cite — see testosterone cypionate vs. enanthate: what the FDA labels actually say.
Testosterone cypionate is testosterone esterified with a cypionate group to slow release after injection. FDA-approved products are used for replacement therapy in males with certain forms of hypogonadism. Once the ester is cleaved, the active hormone is testosterone.
It is commonly prescribed in the United States and is available in commercial and, when clinically appropriate and legally permitted, compounded formulations. See our detailed testosterone cypionate guide.
Testosterone enanthate is another esterified form of testosterone designed for sustained release after injection. It is also used for testosterone replacement and has long-standing clinical use in hypogonadism.
The enanthate ester is slightly shorter than cypionate, but both are considered long-acting preparations. Differences in real-world response are usually smaller than differences caused by dose, injection interval, absorption and the individual patient.
| Factor | Testosterone cypionate | Testosterone enanthate |
|---|---|---|
| Type | Long-acting ester | Long-acting ester |
| Effectiveness for TRT | Effective when appropriately dosed | Effective when appropriately dosed |
| Half-life stated on the FDA label | Approximately eight days (Depo-Testosterone label) | Not stated on the Delatestryl label |
| Labeled dosing interval | Two to four weeks | Two to four weeks |
| Carrier oil | Cottonseed oil, with benzyl benzoate and benzyl alcohol (Depo-Testosterone) | Sesame oil with chlorobutanol (Delatestryl) |
| Controlled substance status | Schedule III | Schedule III |
| Main practical issue | Availability, formulation, tolerability | Availability, formulation, tolerability |
Cypionate is often described as having a slightly longer half-life than enanthate, and this is usually presented as though both figures came from the products' labels. Only one of them does.
The Depo-Testosterone label states it directly: "The half-life of testosterone cypionate when injected intramuscularly is approximately eight days." The Delatestryl label does not state a half-life for enanthate at all — the commonly quoted four-to-five-day figure comes from the pharmacology literature rather than from that label. Both are legitimate sources, but they are not the same kind of claim, and presenting them as an equivalent label-to-label comparison is not accurate.
Published values also vary by formulation, injection route, study design and how pharmacokinetic endpoints are calculated. It is more useful to think of both as long-acting injectable esters with broadly similar clinical behavior — which is also why both labels give the same dosing interval guidance of two to four weeks.
Small differences in ester duration do not justify assuming that every patient on cypionate should inject less often than every patient on enanthate.
No high-quality evidence shows that one ester is universally superior for symptom improvement or testosterone replacement when both are dosed appropriately. The active hormone after ester cleavage is testosterone in either case.
If a patient feels substantially different after switching esters, clinicians should also consider dose equivalence, concentration, carrier oil, injection technique, timing of blood testing and changes in peak-to-trough exposure.
The major systemic adverse effects are driven by testosterone exposure rather than the ester name alone. Both can contribute to elevated hematocrit, acne, oily skin, edema, breast symptoms, fertility suppression, testicular shrinkage, blood-pressure changes and other androgen-related effects.
Individual tolerability can differ because commercial products may use different oils or excipients. A local injection reaction after one product does not necessarily mean the testosterone ester itself is the cause.
Read our guide to TRT side effects.
Injectable testosterone products are dissolved in an oil vehicle, and the two reference products do not use the same one. The Depo-Testosterone label lists cottonseed oil, with benzyl benzoate and benzyl alcohol as a preservative. The Delatestryl label lists sesame oil with chlorobutanol.
This is the difference with the clearest clinical consequence. Sesame is a recognised food allergen, so a patient with a sesame allergy should raise it before enanthate is prescribed — and anyone with a known cottonseed or benzyl alcohol sensitivity should raise it before cypionate is prescribed. The Depo-Testosterone label also carries a warning that benzyl alcohol has been associated with serious adverse events in paediatric patients.
Compounded preparations may use cottonseed, sesame, grapeseed or another appropriate oil depending on the pharmacy. Product formulations are not interchangeable merely because they contain the same testosterone ester.
Patients with injection-site irritation or suspected excipient sensitivity should review the exact manufacturer, concentration and ingredient list rather than assuming they need a different ester.
The term "bioidentical" is often used loosely in hormone marketing. The esterified drug molecule is not identical to endogenous testosterone while the ester is attached. After enzymatic cleavage, the active testosterone released is chemically the same testosterone hormone.
"Bioidentical" should not be treated as a guarantee of greater safety, quality or effectiveness.
Product labeling and real-world TRT practice may use different intervals. Both labels give the same guidance — two to four weeks — and the Delatestryl label adds that injections more frequently than every two weeks are rarely indicated.
Many clinicians use weekly or divided-weekly schedules for cypionate or enanthate to reduce large peak-to-trough swings. That is a real clinical debate with arguments on both sides, and relative to the label language above it is off-label. Frequency should be individualized by the prescriber rather than copied from another patient.
See our guide to TRT dosing and testosterone injection safety.
Yes. Both the Depo-Testosterone and Delatestryl labels state that the product is a Schedule III controlled substance. Testosterone in any ester requires a prescription from a licensed prescriber following an evaluation, and any source offering to supply it without one should be treated with suspicion.
Subcutaneous testosterone regimens are used in clinical practice, and some testosterone products have specific subcutaneous labeling. DEPO-Testosterone cypionate is labeled for intramuscular use, while the XYOSTED enanthate autoinjector is labeled for subcutaneous use in the abdomen only. Route depends on the exact product and prescription. Patients should follow the route on their prescription and product instructions rather than assuming all cypionate or enanthate products are interchangeable by route.
Milligram amounts are often similar in clinical use, but dose changes should not be made casually. Concentration, ester weight, interval and formulation all matter. An unchanged milligram dose may require a different liquid volume when concentration changes; confirm the new volume and syringe markings with the pharmacist. A prescriber should determine the new regimen when switching products.
The objective is not to recreate the same number of milligrams on paper; it is to achieve appropriate testosterone exposure with acceptable symptoms and safety.
Injection interval generally has more influence on peak-to-trough variation than the small pharmacokinetic difference between these two esters. Larger doses given less frequently create greater fluctuation, while smaller divided doses may reduce that variation for some patients.
The best schedule is the one that produces appropriate levels and symptom control without unnecessary adverse effects.
Compounded testosterone may be used when a patient has a clinical need that cannot be met by an available FDA-approved product. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or manufacturing quality in the same way as approved products.
Patients should know the pharmacy, concentration, carrier oil and label instructions for any compounded injectable medication. See our comparison of commercial vs. compounded testosterone.
There is no automatic "winner." The choice depends on availability, prior response, formulation, carrier oil, cost, dosing schedule and patient preference. Testosterone cypionate is commonly used in U.S. TRT practice, but enanthate can be equally reasonable when clinically appropriate.
The decision should be made around the patient rather than around a claim that one ester is stronger, cleaner or more natural.
Not in a clinically meaningful universal sense. Both deliver testosterone, and effectiveness depends primarily on the regimen and achieved hormone levels.
Yes, when appropriate, but the prescription and follow-up plan should be reviewed because concentration, product, interval and excipients may differ.
There is no reliable evidence that one consistently causes less edema or water retention. Testosterone exposure, dose and individual susceptibility matter more.
Neither. Both are exogenous testosterone and can suppress LH, FSH and sperm production. Men with fertility goals should review alternatives and fertility-preserving strategies before starting either. See TRT and fertility.
Medical TRT is not prescribed for bodybuilding or athletic enhancement. The purpose is replacement in appropriately diagnosed testosterone deficiency.
NovaGenix can review symptoms, prior response, laboratory results, fertility goals, formulation preference and side effects before determining an appropriate TRT plan. Learn about Dr. Timothy Mackey, visit About NovaGenix, or review our TRT guide.
Call 561-277-8260 | Text NovaGenix | Schedule a Consultation
This article is educational and does not provide an individual prescription. Testosterone formulation, dose, route and frequency should be determined by the prescribing clinician.
Product references: DEPO-Testosterone label and XYOSTED label.
For follow-up, read our hematocrit monitoring guide.
Speak with NovaGenix about physician-led evaluation, testing, and treatment options in Jupiter, Florida.
Medical disclaimer: This article is for general educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Reading it does not create a physician-patient relationship. Always consult a qualified healthcare professional about your individual circumstances, and never delay seeking care because of something you read here. If you are experiencing a medical emergency, call 911. Read our full Medical Disclaimer.


609 N Hepburn avenue suite 106. Jupiter, Florida 33458
609 N Hepburn avenue suite 106. Jupiter, Florida 33458
561-277-8260
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed